Table 2.
Baseline characteristics of the study cohort.
Characteristic | Control condition (N=72*) |
Intervention condition (N=73*) |
P |
---|---|---|---|
Age | 47.9±6.6 | 49.2±7.4 | 0.24 |
Gender | |||
Male | 35 (48.6%) | 36 (49.3%) | |
Female | 37 (51.4%) | 36 (49.3%) | 0.60 |
Transgender | 0 (0.0%) | 1 (1.4%) | |
Ethnicity | |||
Latino | 18 (25.7%) | 13 (19.7%) | 0.40 |
Non-Latino | 52 (74.3%) | 53 (80.3%) | |
Race | |||
Black/African American | 54 (85.7%) | 55 (85.9%) | |
White | 7 (11.1%) | 7 (10.9%) | 0.99 |
American Indian or Alaskan native | 2 (3.2%) | 2 (3.1%) | |
Marital status | |||
Married/living with partner | 17 (25.8%) | 13 (20.6%) | 0.49 |
Single | 49 (74.2%) | 50 (79.4%) | |
Housing status | |||
Stable | 63 (88.7%) | 66 (90.4%) | |
Transitional | 7 (9.9%) | 6 (8.2%) | 0.94 |
Homeless | 1 (1.4%) | 1 (1.4%) | |
Employment status | |||
Unemployed/disabled | 56 (88.9%) | 61 (87.1%) | |
Part-time employment | 5 (7.9%) | 9 (12.9%) | 0.22 |
Full-time employment | 2 (3.2%) | 0 (0.0%) | |
HIV risk behavior | |||
Heterosexual contact | 46 (63.9%) | 38 (52.8%) | |
Same sex contact | 8 (11.1%) | 13 (18.1%) | |
Injection drug use | 5 (6.9%) | 8 (11.1%) | 0.43 |
Transfusion | 3 (4.2%) | 1 (1.4%) | |
Other/unknown | 10 (13.9%) | 12 (16.7%) | |
Most recent CD4+ count (cells/ul) | 483.2±248.9 | 504.4±326.1 | 0.66 |
Daily cigarette consumption | 11.1±7.3 | 12.8±10.1 | 0.25 |
Nicotine dependence score** | 5.2±2.0 | 4.8±2.1 | 0.19 |
Motivation to quit*** | 7.3±0.9 | 7.4±0.9 | 0.44 |